Carole Crozes

Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patients

Jean‐Philippe Foy, Andy Karabajakian, Sandra Ortiz‐Cuaran et al. · European Journal of Cancer · 2022 · 66 citations

Life Sciences, Immunology, Oncology +17

Wholistic approach: Transcriptomic analysis and beyond using archival material for molecular diagnosis

Nicolas Macagno, Daniel Pissaloux, Arnaud de la Fouchardière et al. · Genes Chromosomes and Cancer · 2022 · 61 citations · Full text

Medicine, Oncology, Pathology +17

Longitudinal assessment of PD-L1 expression and gene expression profiles in patients with head and neck cancer reveals temporal heterogeneity

Andy Karabajakian, Jebrane Bouaoud, Lucas Michon et al. · Oral Oncology · 2021 · 34 citations · Full text

Medicine, Oncology, Pathology +17

Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinoma

Juliette Mainguené, Sophie Vacher, Maud Kamal et al. · Molecular Oncology · 2022 · 31 citations · Full text

Medicine, Molecular Biology, Oncology +17

Hyperprogression and impact of tumor growth kinetics after PD1/PDL1 inhibition in head and neck squamous cell carcinoma

Andy Karabajakian, Thibaut Garrivier, Carole Crozes et al. · Oncotarget · 2020 · 22 citations · Full text

Medicine, Cancer Biology, Oncology +17